Powder: -20°C for 3 years | In solvent: -80°C for 1 year
EBE-A22 (PD153035 Analog 63) is a derivative of PD 153035 which can inhibit ErbB-1-phosphorylation, whereas EBE-A22 is inactive.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 39.00 | |
2 mg | In stock | $ 54.00 | |
5 mg | In stock | $ 84.00 | |
10 mg | In stock | $ 118.00 | |
25 mg | In stock | $ 239.00 | |
50 mg | In stock | $ 363.00 | |
100 mg | In stock | $ 547.00 | |
500 mg | In stock | $ 1,170.00 |
Description | EBE-A22 (PD153035 Analog 63) is a derivative of PD 153035 which can inhibit ErbB-1-phosphorylation, whereas EBE-A22 is inactive. |
Kinase Assay | GAL-021 is dissolved in DMSO, and final assay concentration of DMSO is 0.1% or less. The effects of GAL-021 (30 μM) on a panel of 55 receptors, transporters, and ion channels are evaluated using radioligand binding analyses. Potential kinase inhibition by GAL-021 (10 μM) is assessed using the Kinase HotSpot Screen where activity of 50 kinases is measured in the presence of adenosine triphosphate (10 μM)[1]. |
Synonyms | PD153035 Analog 63 |
Molecular Weight | 374.23 |
Formula | C17H16BrN3O2 |
CAS No. | 229476-53-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 4.12 mg/mL (11.01 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
EBE-A22 229476-53-3 Angiogenesis JAK/STAT signaling Tyrosine Kinase/Adaptors EGFR inhibit Inhibitor EBE-A-22 PD153035 Analog 63 EBE A22 EBEA22 inhibitor